scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...860383K |
P356 | DOI | 10.1371/JOURNAL.PONE.0060383 |
P932 | PMC publication ID | 3614906 |
P698 | PubMed publication ID | 23565238 |
P5875 | ResearchGate publication ID | 236129836 |
P50 | author | Choung-Soo Kim | Q56635696 |
P2093 | author name string | Je-Hwan Lee | |
Jene Choi | |||
Jung Jin Hwang | |||
Se Jin Jang | |||
Seonggu Ro | |||
Hyun Mi Kim | |||
P2860 | cites work | Clinical and biological significance of GSK-3β inactivation in breast cancer-an immunohistochemical study. | Q54656195 |
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells | Q35900933 | ||
Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal | Q37080793 | ||
The role of glycogen synthase kinase-3beta in normal haematopoiesis, angiogenesis and leukaemia | Q37184977 | ||
Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma | Q37481890 | ||
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. | Q39937420 | ||
A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer | Q40075501 | ||
Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor | Q40111979 | ||
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. | Q40134202 | ||
Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells | Q40158471 | ||
MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research | Q40227151 | ||
Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription | Q40372631 | ||
Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells | Q40444210 | ||
Wnt signaling controls the phosphorylation status of beta-catenin. | Q42162259 | ||
Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations | Q42791472 | ||
Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells | Q46735228 | ||
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage | Q24534352 | ||
GSK-3: tricks of the trade for a multi-tasking kinase | Q24624069 | ||
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis | Q24655172 | ||
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation | Q24655658 | ||
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics | Q24685475 | ||
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 | ||
Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
Molecular cloning and expression of glycogen synthase kinase-3/factor A | Q28569645 | ||
The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
The glamour and gloom of glycogen synthase kinase-3 | Q29620533 | ||
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53 | Q34338748 | ||
Glycogen synthase kinase 3: an emerging therapeutic target | Q34552674 | ||
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. | Q35204486 | ||
GSK3 inhibitors: development and therapeutic potential | Q35790372 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell death | Q2383867 |
P304 | page(s) | e60383 | |
P577 | publication date | 2013-04-02 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells | |
P478 | volume | 8 |
Q91592473 | Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling |
Q93185115 | CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor |
Q54302548 | Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth. |
Q92290872 | GSK3-β Stimulates Claspin Degradation via β-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival |
Q35667570 | Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease |
Q37640802 | Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer. |
Q64250238 | MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer |
Q39067484 | Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer |
Q57107973 | Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer |
Q28854594 | The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways |
Q28551465 | Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway |
Q47299786 | WNT Signaling in Cardiac and Vascular Disease. |
Search more.